284 related articles for article (PubMed ID: 25028599)
1. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.
Pawar S; Donthamsetty S; Pannu V; Rida P; Ogden A; Bowen N; Osan R; Cantuaria G; Aneja R
J Ovarian Res; 2014; 7():53. PubMed ID: 25028599
[TBL] [Abstract][Full Text] [Related]
2. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
Mittal K; Choi DH; Klimov S; Pawar S; Kaur R; Mitra AK; Gupta MV; Sams R; Cantuaria G; Rida PCG; Aneja R
J Ovarian Res; 2016 Mar; 9():17. PubMed ID: 26992853
[TBL] [Abstract][Full Text] [Related]
3. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
Li J; Diao H; Guan X; Tian X
Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
[TBL] [Abstract][Full Text] [Related]
4. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients.
Pannu V; Rida PC; Ogden A; Turaga RC; Donthamsetty S; Bowen NJ; Rudd K; Gupta MV; Reid MD; Cantuaria G; Walczak CE; Aneja R
Oncotarget; 2015 Mar; 6(8):6076-91. PubMed ID: 25788277
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
6. The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation.
Fan G; Sun L; Meng L; Hu C; Wang X; Shi Z; Hu C; Han Y; Yang Q; Cao L; Zhang X; Zhang Y; Song X; Xia S; He B; Zhang S; Wang C
Nat Commun; 2021 Jan; 12(1):20. PubMed ID: 33397932
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
8. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
[TBL] [Abstract][Full Text] [Related]
9. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
10. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
12. High KIFC1 expression is associated with poor prognosis in prostate cancer.
Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
[TBL] [Abstract][Full Text] [Related]
13. IFT proteins interact with HSET to promote supernumerary centrosome clustering in mitosis.
Vitre B; Taulet N; Guesdon A; Douanier A; Dosdane A; Cisneros M; Maurin J; Hettinger S; Anguille C; Taschner M; Lorentzen E; Delaval B
EMBO Rep; 2020 Jun; 21(6):e49234. PubMed ID: 32270908
[TBL] [Abstract][Full Text] [Related]
14. High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma.
Ma Y; Ren Y; Zhang X; Lin L; Liu Y; Rong F; Wen W; Li F
Virchows Arch; 2014 Apr; 464(4):443-52. PubMed ID: 24458516
[TBL] [Abstract][Full Text] [Related]
15. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
[TBL] [Abstract][Full Text] [Related]
16. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
17. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract][Full Text] [Related]
18. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.
Saatci O; Akbulut O; Cetin M; Sikirzhytski V; Uner M; Lengerli D; O'Quinn EC; Romeo MJ; Caliskan B; Banoglu E; Aksoy S; Uner A; Sahin O
Cell Death Differ; 2023 May; 30(5):1305-1319. PubMed ID: 36864125
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell.
Parvin A; Hao SL; Tan FQ; Yang WX
Gene; 2020 Nov; 760():144989. PubMed ID: 32717307
[TBL] [Abstract][Full Text] [Related]
20. Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer.
Mittermeyer G; Malinowsky K; Beese C; Höfler H; Schmalfeldt B; Becker KF; Avril S
PLoS One; 2013; 8(10):e77825. PubMed ID: 24204986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
